Loading...
Xvivo Perfusion AB (publ)
XVIPY•PNK
Healthcare
Medical - Specialties
$7.50
$-0.20(-2.60%)
Xvivo Perfusion AB (publ) (XVIPY) Financial Performance & Statements
Review Xvivo Perfusion AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
37.63%
↑ 37.63%
Operating Income Growth
2010.17%
↑ 2010.17%
Net Income Growth
87.52%
↑ 87.52%
Operating Cash Flow Growth
140.43%
↑ 140.43%
Operating Margin
6.36%
↑ 6.36%
Gross Margin
70.51%
↑ 70.51%
Net Profit Margin
27.21%
↑ 27.21%
ROE
10.14%
↑ 10.14%
ROIC
2.24%
↑ 2.24%
Xvivo Perfusion AB (publ) (XVIPY) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Xvivo Perfusion AB (publ) stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $227.56M | $198.48M | $210.35M | $186.02M |
| Cost of Revenue | $52.43M | $50.55M | $52.10M | $50.92M |
| Gross Profit | $175.13M | $147.93M | $158.24M | $135.11M |
| Gross Profit Ratio | $0.77 | $0.75 | $0.75 | $0.73 |
| R&D Expenses | $55.81M | $30.86M | $31.07M | $30.59M |
| SG&A Expenses | $103.85M | $95.93M | $94.003M | $85.99M |
| Operating Expenses | $159.67M | $127.46M | $124.82M | $116.11M |
| Total Costs & Expenses | $212.10M | $178.008M | $176.92M | $167.03M |
| Interest Income | $0.00 | $67.21M | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $781000.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $10.22M | $16.95M |
| EBITDA | $15.46M | $20.47M | $51.14M | $28.54M |
| EBITDA Ratio | $0.07 | $0.10 | $0.24 | $0.15 |
| Operating Income | $15.46M | $20.47M | $33.43M | $18.99M |
| Operating Income Ratio | $0.07 | $0.10 | $0.16 | $0.10 |
| Other Income/Expenses (Net) | $34.15M | $67.21M | -$781000.00 | $11.02M |
| Income Before Tax | $49.62M | $87.68M | $32.65M | $30.008M |
| Income Before Tax Ratio | $0.22 | $0.44 | $0.16 | $0.16 |
| Income Tax Expense | $13.23M | $1.86M | $5.45M | $7.22M |
| Net Income | $36.39M | $85.82M | $27.19M | $22.79M |
| Net Income Ratio | $0.16 | $0.43 | $0.13 | $0.12 |
| EPS | $1.16 | $2.72 | $0.86 | $0.72 |
| Diluted EPS | $1.15 | $2.71 | $0.86 | $0.72 |
| Weighted Avg Shares Outstanding | $31.50M | $31.50M | $31.62M | $31.50M |
| Weighted Avg Shares Outstanding (Diluted) | $31.65M | $31.69M | $31.62M | $31.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan